Product image of Levetiracetam Mylan (Levetiracetam) supplied by GNH India

Levetiracetam Mylan

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Mylan (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Mylan, is an Anticonvulsant presented as a tablet for oral use. It is employed to control various types of epileptic seizures, including partial, myoclonic and primary generalized tonic‑clonic seizures, in patients diagnosed with epilepsy across the European Union.

GNH India supplies Levetiracetam Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory conformity for global health care providers.

Manufacturer / TM Owner

Generics [uk] Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levetiracetam is an antiepileptic drug that modulates neuronal excitability to treat several seizure types.

  • Partial seizures: reduces frequency of focal onset seizures in patients with epilepsy.
  • Myoclonic seizures: decreases occurrence of sudden, brief muscle jerks associated with myoclonic epilepsy.
  • Primary generalized tonic‑clonic seizures: helps prevent convulsive seizures that involve the whole brain.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This interaction modulates synaptic vesicle exocytosis, stabilizing neuronal firing and diminishing hyper‑excitability. By reducing the release of excitatory neurotransmitters, the drug lowers the likelihood of seizure propagation without significant effects on ion channels or G‑protein coupled receptors.

Side Effects

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Dizziness
  • Fatigue
  • Somnolence
  • Irritability
  • Headache
  • Nausea

Serious or Rare Side Effects

  • Severe allergic reactions (e.g., angioedema, anaphylaxis)
  • Stevens‑Johnson syndrome or toxic epidermal necrolysis
  • Suicidal thoughts or behavior
  • Severe skin rash with blistering
  • Blood dyscrasias such as neutropenia or thrombocytopenia
  • Multi‑organ hypersensitivity reactions

Precautions & Warnings

Before initiating therapy, consider the following precautions to ensure safe use of levetiracetam.

  • Renal impairment: dose may need adjustment based on creatinine clearance.
  • Pregnancy: risk category unknown; discuss potential benefits and risks with a healthcare professional.
  • Breastfeeding: unknown excretion in milk; evaluate necessity of treatment versus infant exposure.
  • Psychiatric symptoms: monitor for mood changes, depression, or agitation.
  • Concomitant CNS depressants: observe for enhanced sedation or respiratory depression.
  • Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Carbamazepine: induces metabolism, decreasing levetiracetam plasma levels.
  • Phenobarbital: enzyme induction leading to reduced levetiracetam exposure.
  • Phenytoin: increases clearance of levetiracetam, potentially lowering effectiveness.
  • Rifampin: strong inducer that may markedly lower levetiracetam concentrations.
  • St. John’s wort: herbal inducer that can reduce levetiracetam levels.

Moderate Interactions (Monitor Closely)

  • Alcohol: additive CNS depression may increase sedation.
  • Other antiepileptics (e.g., valproate): may require dose adjustments.
  • Oral contraceptives: levetiracetam may reduce hormonal efficacy, consider alternative contraception.
  • Antidepressants (e.g., SSRIs): monitor for increased irritability or mood changes.
  • NSAIDs: observe for any change in seizure control or side‑effect profile.

Frequently Asked Questions

Levetiracetam Mylan is prescribed to treat epilepsy. It is indicated for partial seizures, myoclonic seizures, and primary generalized tonic‑clonic seizures, helping to reduce the frequency and severity of these seizure types in patients diagnosed with epilepsy.

Levetiracetam binds to the synaptic vesicle protein SV2A, which regulates neurotransmitter release. This binding modulates vesicle exocytosis, stabilizing neuronal firing and decreasing the release of excitatory neurotransmitters, thereby lowering neuronal hyper‑excitability and seizure activity.

The appropriate dose of Levetiracetam Mylan is individualized by the prescribing clinician based on factors such as the patient’s age, weight, renal function, seizure type, and response to therapy. No fixed dosing regimen is provided here.

Levetiracetam is classified as having an unknown pregnancy risk category. Healthcare providers should weigh potential benefits against possible risks before prescribing to pregnant or nursing women, and discuss alternative options when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers or GABA‑enhancers. It generally has a favorable drug‑interaction profile, minimal enzyme induction, and is often well‑tolerated, making it a useful alternative or adjunct to traditional antiepileptics such as carbamazepine, valproate, or phenytoin.

Store Levetiracetam Mylan below 25 °C in its original packaging. Keep the tablets away from moisture, direct sunlight, and excessive heat to maintain product stability and potency.

Levetiracetam Mylan is taken orally, usually as a tablet. It should be swallowed with water and may be taken with or without food, following the dosing schedule prescribed by the treating physician.

Serious risks include severe allergic reactions, Stevens‑Johnson syndrome or toxic epidermal necrolysis, suicidal thoughts or behaviors, significant skin rashes, and blood disorders such as neutropenia or thrombocytopenia. Patients should seek immediate medical attention if any of these symptoms occur.

Levetiracetam Mylan should be avoided in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is also advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking medications that may cause major drug interactions without appropriate monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT